Logo image of VEON

VEON LTD (VEON) Stock Analyst Earnings Estimates

NASDAQ:VEON - Nasdaq - US91822M5022 - ADR - Currency: USD

56.2  +2.73 (+5.12%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
VEON revenue by date.VEON revenue by date.
3.755B
-2.47%
3.698B
-1.52%
4.004B
8.27%
4.3B
7.39%
4.612B
7.26%
4.863B
5.44%
5.127B
5.43%
5.176B
0.96%
5.383B
4.00%
EBITDA
YoY % growth
VEON ebitda by date.VEON ebitda by date.
1.64B
-12.16%
1.606B
-2.07%
N/A
4.92%
1.832B
8.72%
2.044B
11.57%
2.235B
9.34%
2.371B
6.09%
2.415B
1.86%
2.52B
4.35%
EBIT
YoY % growth
VEON ebit by date.VEON ebit by date.
969M
-6.92%
877M
-9.49%
963M
9.81%
1.037B
7.68%
1.228B
18.42%
1.416B
15.31%
1.589B
12.22%
1.581B
-0.50%
1.665B
5.31%
Operating Margin
VEON operating margin by date.VEON operating margin by date.
25.81%23.72%24.05%24.12%26.63%29.12%30.99%30.54%30.93%
EPS
YoY % growth
VEON eps by date.VEON eps by date.
N/A
-96.04%
N/A
1,277.93%
N/A
17.26%
5.08
-2.48%
7.26
42.97%
8.78
20.88%
11.19
27.50%
12.51
11.73%
13.36
6.85%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth
1.40
-53.42%
1.37
39.47%
Revenue
Q2Q % growth
1.068B
2.99%
1.098B
10.02%
EBITDA
Q2Q % growth
471.24M
-41.32%
483.48M
21.20%
EBIT
Q2Q % growth
261.12M
2.00%
269.28M
19.68%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
8.30 0.977.33756.55%
Q1 2025
Q2Q % growth
1.36 0.850.5160.64%
Q4 2024
Q2Q % growth
0.98 0.790.1924.78%
Q3 2024
Q2Q % growth
3.00
4,185.71%
3.01-0.01-0.30%
Q3 2021
Q2Q % growth
2.25
2,400.00%
2.81-0.56-19.79%
Q2 2021
Q2Q % growth
1.50
2,900.00%
1.96-0.46-23.28%
Q1 2021
Q2Q % growth
1.75
2,816.67%
1.79-0.04-1.96%
Q4 2020
Q2Q % growth
0.75
7,400.00%
0.510.2447.06%
Q3 2020
Q2Q % growth
0.09
350.00%
0.050.0496.08%
Q2 2020
Q2Q % growth
0.05
25.00%
0.010.04880.39%
Q1 2020
Q2Q % growth
0.06
-40.00%
0.060.00-1.96%
Q4 2019
Q2Q % growth
0.01 0.010.00-1.96%
Q3 2019
Q2Q % growth
0.02 0.05-0.03-60.78%
Q2 2019
Q2Q % growth
0.04 0.09-0.05-56.43%
Q1 2019
Q2Q % growth
0.10 0.060.0463.40%
VEON Yearly EPS VS EstimatesVEON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
1.087B
5.84%
1.044B43M4.12%
Q1 2025
Q2Q % growth
1.026B
8.92%
1.016B10M0.98%
Q4 2024
Q2Q % growth
998M
4.72%
1.017B-19M-1.87%
Q3 2024
Q2Q % growth
1.037B
9.74%
1.059B-22M-2.08%
Q2 2024
Q2Q % growth
1.027B
12.12%
%
Q1 2024
Q2Q % growth
942M
6.56%
%
Q4 2023
Q2Q % growth
953M
1.49%
%
Q3 2023
Q2Q % growth
945M
6.06%
%
Q2 2023
Q2Q % growth
916M
-4.28%
%
Q1 2023
Q2Q % growth
884M
-8.68%
%
Q4 2022
Q2Q % growth
939M
149.76%
%
Q3 2022
Q2Q % growth
891M
-55.56%
%
Q2 2022
Q2Q % growth
957M
-49.68%
%
Q1 2022
Q2Q % growth
968M
-47.10%
%
Q4 2021
Q2Q % growth
-1.887B
-203.17%
%
Q3 2021
Q2Q % growth
2.005B
10.23%
2.122B-117M-5.51%
Q2 2021
Q2Q % growth
1.902B
23.03%
2.06B-158M-7.67%
Q1 2021
Q2Q % growth
1.83B
-12.73%
2.045B-215M-10.51%
Q4 2020
Q2Q % growth
1.829B
-18.89%
2.012B-183M-9.10%
Q3 2020
Q2Q % growth
1.819B
-18.21%
2.042B-223M-10.92%
Q2 2020
Q2Q % growth
1.546B
-31.62%
1.966B-420M-21.36%
Q1 2020
Q2Q % growth
2.097B
-1.27%
2.105B-8M-0.38%
Q4 2019
Q2Q % growth
2.255B 2.306B-51M-2.21%
Q3 2019
Q2Q % growth
2.224B 2.314B-90M-3.89%
Q2 2019
Q2Q % growth
2.261B 2.256B5M0.22%
Q1 2019
Q2Q % growth
2.124B 2.169B-45M-2.07%
VEON Yearly Revenue VS EstimatesVEON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS13.1% -8.65% 0% 0.88%
Revenue0% 0.29% 0.07% 1.32%